CIK 0001802768
- Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 212-883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,573,345
- in 6 filings, $32.6M under 10b5-1 plans
Net −$32,573,345. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-17 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −14,751 | $68.30 | $1.0M | 0 |
| 2026-11-17 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −9,835 | $68.30 | $672K | 0 |
| 2026-11-17 | Hite Christopher EVP & Chairman, Partnering | Sale 10b5-1 | −100,000 | $68.15 | $6.8M | 177,523 |
| 2026-11-16 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −23,592 | $69.47 | $1.6M | 126,408 |
| 2026-11-16 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −1,408 | $69.99 | $99K | 125,000 |
| 2026-11-16 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −135,249 | $68.87 | $9.3M | 14,751 |
| 2026-11-16 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −90,165 | $68.87 | $6.2M | 9,835 |
| 2026-11-16 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −7,122 | $68.87 | $490K | 0 |
| 2026-11-06 | Urist Marshall EVP, Research & Investments | Conversion | +150,000 | 150,000 | ||
| 2026-11-06 | Urist Marshall EVP, Research & Investments | Conversion · LP interests in RPI US Partners 2019, LP | −15,000 | 229,412 | ||
| 2026-11-06 | Coyne Terrance P. EVP & CFO | Conversion | +150,000 | 150,000 | ||
| 2026-11-06 | Coyne Terrance P. EVP & CFO | Conversion | +100,000 | 100,000 | ||
| 2026-11-06 | Coyne Terrance P. EVP & CFO | Conversion · LP interests in RPI US Partners 2019, LP | −15,000 | 102,526 | ||
| 2026-11-06 | Coyne Terrance P. EVP & CFO | Conversion · LP interests in RPI US Partners 2019, LP | −10,000 | 473,942 | ||
| 2026-11-04 | Urist Marshall EVP, Research & Investments | Grant or award | +5,341 | 5,341 | ||
| 2026-11-04 | Coyne Terrance P. EVP & CFO | Grant or award | +7,122 | 7,122 | ||
| 2026-11-04 | Hite Christopher EVP & Chairman, Partnering | Grant or award | +7,122 | 277,523 | ||
| 2026-11-04 | Legorreta Pablo G. CEO, Chairman of the Board | Grant or award | +42,209 | 1,350,029 | ||
| 2026-10-05 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −4,126 | $57.10 | $236K | 0 |
| 2026-09-30 | Bassler Bonnie L Director | Grant or award | +642 | $58.41 | $37K | 79,823 |
Page 1 of 16 · 315 trades